Neurogene NGNE
NASDAQ NGNE
$38.60 +0.99 (+2.63%)
At close: Sep 4, 2026 · 4:00 PM EDT

Neurogene (NGNE) Amortizatization of Intangibles (2020 - 2026)

Neurogene's (NGNE) quarterly Amortizatization of Intangibles came in at $7000.0 in Q1 2026, down 46.15% YoY from $13000.0 in Q1 2025, and down 98.6% on a QoQ basis from $500000.0 in Q4 2025.

Analysis

Neurogene (NGNE) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Neurogene (NGNE) has 5 years of Amortizatization of Intangibles data on file, last reported at $7000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 46.15% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $531000.0 (down 78.08% YoY) and the FY2025 annual result came in at $4.5 million, up 87.52% from the prior year.
  • Amortizatization of Intangibles fell to $7000.0 in Q1 2026, from $500000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q4 2024 to a low of -$105000.0 in Q4 2022.
  • A 5-year average of $205800.0 and a median of $12000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles slumped 90.74% — and 2024, when it surged 2166.67%.
  • Tracing NGNE's Amortizatization of Intangibles over 5 years: stood at -$105000.0 in 2022, then surged by 200.0% to $105000.0 in 2023, then surged by 2166.67% to $2.4 million in 2024, then sank by 78.99% to $500000.0 in 2025, then sank by 98.6% to $7000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $7000.0 (Q1 2026), $500000.0 (Q4 2025), and $12000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Neurogene 864.53 Mn 864.53 Mn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 374,000.00
Dec 31, 2025 500,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 12,000.00
Mar 31, 2025 1.75 Mn
Dec 31, 2024 959,000.00
Sep 30, 2024 12,000.00
Jun 30, 2024 17,000.00
Mar 31, 2024 446,000.00
Dec 31, 2023 81,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 8,000.00
Mar 31, 2023 6,000.00
Dec 31, 2022 -772,000.00
Sep 30, 2022 267,000.00
Jun 30, 2022 259,000.00
Mar 31, 2022 250,000.00
Dec 31, 2021 241,000.00
Sep 30, 2021 236,000.00